Evidence map›Paper›PMID 25623292›Full record

Trial reportContemporary clinical trials2015

Impact of periodontal disease on outcomes in diabetes.

Kenneth Izuora, Echezona Ezeanolue, Karen Schlauch, Michael Neubauer, Civon Gewelber, Guillermo Umpierrez

Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in Contemporary clinical trials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03764410 (Evaluation of Periodontal Clinical Parameters and Blood Tests in Diabetic Patients Submitted to Non-surgical Periodontal Treatment), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03764410 nacompletednot on this mapstarted 2016, after this paper: background citation

Evaluation of Periodontal Clinical Parameters and Blood Tests in Diabetic Patients Submitted to Non-surgical Periodontal Treatment

TypeinterventionalSponsorUniversidade Metropolitana de SantosRan2016 to 2017Enrolled120ConditionsDiabetes Mellitus, Type 2, Periodontal DiseasesArmsNon-surgical periodontal treatment
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Quantification of TNF-BioMed research international · 2019
    Article
  4. Article
  5. DENTAL LOSS AMONG AMBULATORY PATIENTS WITH DIABETES.Journal of clinical & translational endocrinology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kenneth IzuoraInternal Medicine, University of Nevada School of Medicine - Las Vegas, Administration Building, Suite 300, 2040 West Charleston Boulevard, Las Vegas, NV 89102, USA. Electronic address: kizuora@medicine.nevada.edu.
Echezona EzeanoluePediatrics, University of Nevada School of Medicine - Las Vegas, Administration Building, Suite 402, 2040West Charleston Boulevard, Las Vegas, NV 89102, USA. Electronic address: eezeanolue@medicine.nevada.edu.
Karen SchlauchBiochemistry and Molecular Biology, University of Nevada - Reno, Howard Medical Sciences Building, Suite 330, 1664 North Virginia Street, Reno, NV 89557, USA. Electronic address: schlauch@unr.edu.
Michael NeubauerSchool of Dental Medicine, University of Nevada - Las Vegas, 1700 West Charleston Boulevard, Las Vegas, NV 89102, USA. Electronic address: michael.neubauer@unlv.edu.
Civon GewelberSchool of Dental Medicine, University of Nevada - Las Vegas, 1700 West Charleston Boulevard, Las Vegas, NV 89102, USA. Electronic address: civon.gewelber@sdm.unlv.edu.
Guillermo UmpierrezEndocrinology, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, GA 30322, USA. Electronic address: geumpie@emory.edu.
University of Nevada, Las Vegas · USEmory University · USUniversity of Nevada, Reno · US

Funding

Tracking and EvaluationU54GM104944 · NIGMS · UNIVERSITY OF NEVADA LAS VEGAS · PI ZHU, YILIANG · 2013 to 2023
$39.6M
NIGMS NIH HHS 1U54GM104944-01NIGMS NIH HHS U54 GM104944
6 · The paper itself

Abstract

introductionThe prevalence of periodontal disease (POD) among adults aged 30years and older in the United States is reported to be more than 47%, with higher prevalence seen among patients with diabetes mellitus (DM). POD has been associated with systemic inflammation, a known risk factor for cardiovascular and bone disease, both of which are more common in patients with DM. However, there is mixed evidence that treatment of POD reduces inflammation, improves DM control, and reduces DM complications. Our study objectives are to assess factors associated with POD in patients with DM and determine the impact of POD treatment on inflammation and bone turnover biomarkers associated with complications of DM.

methodsIn this pilot study, we will first recruit 200 patients with DM to complete a 48-item investigator-administered questionnaire designed to assess socio-economic status, oral health status, adequacy of oral care, glycemic control and presence of DM complications. Responses will be verified by individual chart review. Then, using a crossover design, a subgroup of 24 subjects with responses suggestive of POD will be assigned to undergo POD treatment for three months followed by three months of routine dental care (group 1) or be followed for three months during routine dental care then receive POD treatment for three months (group 2). Outcome measures will be collected before and after POD treatment and include glycemic control and inflammatory and bone turnover biomarkers.

resultsWe hypothesize that the prevalence of POD among DM patients will be associated with inadequate glycemic control and greater DM complications.

Indexed as

AdultAlkaline PhosphataseBlood GlucoseCollagen Type IC-Reactive ProteinCross-Over StudiesCross-Sectional StudiesDiabetes ComplicationsDiabetes MellitusGlycated HemoglobinHumansInflammationPeptidesPeriodontal DiseasesPilot ProjectsRisk FactorsAlkaline PhosphataseBlood GlucoseCollagen Type Icollagen type I trimeric cross-linked peptideC-Reactive ProteinGlycated Hemoglobinhemoglobin A1c protein, humanPeptidesTumor Necrosis Factor-alphaBone turnover biomarkersDiabetes complicationsGlycemic controlInflammation biomarkersPeriodontal disease

Identifiers

PMID25623292
PMCPMC4380752
OpenAlexW2097747317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.